Tumor Cells Express Fcγrl Which Contributes to Tumor Cell Growth and a Metastatic Phenotype
Total Page:16
File Type:pdf, Size:1020Kb
RESEARCH ARTICLE Neoplasia . Vol. 3, No. 2, 2001, pp. 115 ± 124 115 www.nature.com/neo Tumor Cells Express Fc RI Which Contributes to Tumor Cell Growth and a Metastatic Phenotype M. Bud Nelson, Julie K. Nyhus, Katherine I. Oravecz-Wilson and Emilio Barbera-Guillem BioCrystal Ltd., Westerville, OH Abstract High levels of circulating immune complexes containing epitope, and the shed tumor±associated antigen complexes tumor-associated antigens are associated with a poor with this IgG antibody in forming polyvalent immune prognosis for individuals with cancer. The ability of B complexes. The polyvalent immune complexes cross-link cells, previously exposed to tumor-associated anti- Fc RonFc R-expressing immune effector cells, such as gens, to promote both in vitro and in vivo tumor growth monocytes and interferon-gamma±activated polymorpho- formed the rationale to evaluate the mechanism by nuclear cells, in a process that results in release in the tumor which immune complexes may promote tumor growth. stroma of soluble mediators, which promote tumor cell In elucidating this mechanism, Fc RI expression by invasion, angiogenesis, and metastasis. Thus, there is a tumor cells was characterized by flow cytometry, mechanism by which B cells and antitumor antibodies, as polymerase chain reaction, and sequence analysis. mediated by immune effector cells, can induce tumor Immune complexes containing shed tumor antigen and progression [7]. A direct antibody±tumor cell interaction anti±shed tumor antigen Ab cross-linked Fc RI-ex- has been proposed to involve IgM, which binds tumor cell- pressing tumor cells, which resulted in an induction of associated antigen, thereby coating and masking the tumor tumor cell proliferation and of shed tumor antigen cells, protecting them from attack by cytotoxic lymphocytes production. Use of selective tyrosine kinase inhibitors and allowing for progressive growth of the tumor [9]. demonstrated that tumor cell proliferation induced by Independent of these discoveries, it has been proposed that immune complex cross-linking of Fc RI is dependent nonlymphoid tumors, experimental and human, express on the tyrosine kinase signal transduction pathway. A Fc R identified as Fc RIIB1 [10]. Although the mechan- selective inhibitor of phosphatidylinositol-3 kinase also ism(s) by which Fc RIIB1 may confer augmentation of inhibited this induction of tumor cell proliferation. These tumorigenicity remains unknown, it was suggested that findings support a role for immune complexes and Fc RI complexed IgG, bound by Fc RIIB1 on tumor cells, could expression by tumor cells in augmentation of tumor sterically block immune effector mechanisms from eliminat- growth and a metastatic phenotype. Neoplasia (2001) 3, ing the tumor cells. 115±124. We have observed that mucin-secreting tumor cells appeared to be able to interact directly with B cells to Keywords: B lymphocytes, tumor, cellular proliferation, Fc receptors, signal transduction. modulate tumor cell behavior. Here, we characterized this interaction and found that the B cells require prior exposure to tumor-associated antigens, that a tumor cell Introduction receptor for mediating this interaction is Fc RI, and that it Despite the activation of lymphocytes such as NK cells, T is immune complex binding and cross-linking of this cells, and B cells by tumor antigens, the immune system is receptor, which induces both tumor cell proliferation and often inefficient in both eliminating the tumor and preventing production of mucin with polyvalent sialyl-Tn (sTn) antigen its progressive growth. There have been several proposed (sTn-mucin). mechanisms by which tumor cells may evade immune attack by inducing apoptosis of lymphocytes, including by expres- sion of Fas ligand, and by some tumor-associated antigens Materials and Methods such as RCAS1 and Muc-1 [1±4]. Additionally, it has also been proposed that B cells may be involved in lymphocyte Cell Lines suppression, thereby allowing tumor cells to escape T-47D (human ductal breast carcinoma), SW620 (human mechanisms of T cell±mediated cytotoxicity [5,6]. Further, colon carcinoma), B16F1 (C57BL murine melanoma), and we have identified a novel mechanism by which B cells contribute to the promotion of tumor growth, invasion, and Abbreviations: sTn, sialyl Tn; B - TIL, tumor - infiltrating B lymphocytes; TIL, tumor - metastasis in cooperation with immune effector cells [7,8]. infiltrating T lymphocytes; PI - 3 kinase, phosphatidylinositol - 3 kinase Address all correspondence to: Emilio Barbera - guillem, BioCrystal Ltd., 575 McCorkle Briefly, B cells are activated by shed tumor±associated Boulevard, Westerville, OH 43082 - 8888. E-mail: [email protected] antigens in a humoral immune response resulting in the Received 11 October 2000; Accepted 28 November 2000. production of IgG antibody against a repeated carbohydrate Copyright # 2001 Nature Publishing Group All rights reserved 1522-8002/01/$17.00 116 Contribution of Fc RI Expression to Tumor Cell Malignancy Nelson et al. U937 (monocytic) cell lines were obtained from ATCC Fc R Expression (Rockville, MD). The Met 129 (methylcholanthrene-induced B16F1 tumor cells, T-47D tumor cells, and Met 129 tumor mammary carcinoma in C3H mice) cell line was kindly cells were each cultured as an adherent monolayer provided by Dr J. Vaage (Roswell Park Memorial Institute, (378C+5% CO2 ) in serum-free tissue culture medium; Buffalo, NY). SW620 tumor cells were cultured in suspension with agitation (378C) in serum-free tissue culture medium. The Mice respective tumor cells were harvested, washed twice with C3H mice and athymic nude C3H mice (nu/nu) were PBS, centrifuged at 1200 rpm for 10 minutes, and then purchased from Harlan Sprague-Dawley. The use of resuspended in PBS without calcium and magnesium. Cells experimental animals, and animal care, was in accordance were counted, and cell viability was checked using trypan with both the NIH and European Community principles of blue exclusion dye. Cells were aliquoted at a concentration of laboratory animal care. 1 million cells per tube, and resuspended in 50 lofan antibody solution selected from fluoroscein isothiocyanate (FITC)-labeled anti-Fc RI (CD64), phycoerythrin (PE)- In Vivo Tumor Growth labeled anti-Fc RII (CD32), R-phycoerythrin-cyanin 5.1 B cells were isolated as described previously [7] using (PC5)-labeled anti-Fc RIII (CD16), PE-labeled isotype anti-B220 mAb, selected using magnetic beads coated with control IgG1 mAb, or PE-labeled isotype control IgG2 mAb sheep anti-rat IgG (Dynal), and cultured in RPMI. Flow (fluorescent dye±labeled mAbs all obtained from Immuno- cytometry was used to confirm that greater than 90% of tech, Coulter). After staining for 30 minutes on ice, 800 lof these isolated cells were B220+. C3H mice or athymic nude PBS was added, the cells were pelleted by centrifugation at 6 C3H mice were injected intrasplenically with 10 Met 129 3000 rpm for 3 minutes, and the supernatants were removed. tumor cells. Starting 5 days later, the mice were injected The cell pellets were then resuspended in 250 to 350 lof every 2 days for a 14-day period with either B cells (50,000 PBS for analysis by flow cytometry. Each value was cells/100 l) isolated from normal mouse spleen, or isolated corrected for nonspecific binding by subtracting the value from spleens of tumor-bearing mice, or isolated from tumors of the respective isotype control. For analysis of Fc RI of tumor-bearing mice, or received no injection of B cells. expression at the mRNA level, RNA isolation, RT/PCR After the 14-day period, liver metastasis and spleen tumor conditions, primers, PCR conditions for cDNA amplification, was scored by assigning a numerical value where ``0'' and analysis by agarose gel electrophoresis were per- represents no metastasis (as proven by histology); ``1'' formed as described by Ernst et al. [11]. U937 monocytic represents a single metastases in one liver lobe; ``2'' cell RNA was used as a control for expression of all 3 represents several metastases in one liver lobe; ``3'' Fc RI genes. Fc RI-specific primers included 50 -ACAC- represents multiple metastases involving several liver lobes; CACAAAGGCAGTGA-30 and reverse primer 50 -CACCCA- and ``4'' represents greater than 50% of the liver mass is GAGAACAGTGTT-30. DNA sequencing was performed tumor. The degree of spleen tumor was scored by assigning commercially. a numerical value, where: ``0'' represents no tumor (as proven by histology); ``1'' represents a small tumor; ``2'' Immune Complex Induction of Tumor Proliferation represents a large tumor with visible spleen; ``3'' represents a Either B72.3 mAb (IgG1; ATCC) or HB-STn mAb large tumor in which only a portion of the spleen shape is (IgG1; Dako) were used as the anti-sTn mAb. For initial visible; and ``4'' represents a tumor so large that the spleen induction experiments, sTn-mucin±secreting tumor cells shape is no longer visible. Each individual score was were aliquoted into 96-well plates at 1000 cells per well. squared, and then the values for the group being analyzed After culture overnight (378Cin5%CO2 ), the culture were averaged to obtain a single value representative of that medium from each well was removed, and replaced with group. fresh serum-free tissue culture medium alone or with anti-sTn mAb (HB-STn) to a final concentration of either In Vitro Tumor Growth in Presence of B Cells 10, 1, 0.1, or 0.01 g/ml, for a total of six wells per Tumor infiltrating CD8+ lymphocytes were isolated from control or antibody dilution.